Bone Marrow Transplantation in Cancer, a relentless adversary that affects millions of lives each year, requires a multifaceted approach to treatment.
One such approach that has been pivotal in the battle against cancer is bone marrow transplantation, a procedure that offers new hope to patients facing the most challenging forms of this disease.
Bone marrow transplantation in cancer, often referred to as hematopoietic stem cell transplantation (HSCT), is a medical procedure that has emerged as a beacon of hope for individuals battling certain types of cancer, particularly those involving the blood and bone marrow.
There are several types of bone marrow transplantation, with the two primary categories being autologous and allogeneic transplants.
In an autologous transplant, the patient’s own stem cells are collected and stored before undergoing intensive chemotherapy, which is a common treatment method for bone marrow cancer, and radiation therapy.
Allogeneic transplants involve the use of stem cells donated by a healthy, tissue-matched individual, typically a sibling or an unrelated donor. This type of transplant is crucial for patients with leukaemia, aplastic anaemia, and other blood-related disorders.
Bone marrow transplantation in cancer treatment is particularly beneficial when the cancer has invaded the bone marrow itself or when extremely high doses of chemotherapy and radiation are needed to eradicate the disease.
By replacing the patient’s unhealthy bone marrow with healthy stem cells, these procedures can essentially “reset” the immune system, providing a fresh start for the patient’s body to combat the cancer.
Leukaemia, a cancer that primarily affects the blood and bone marrow, is one of the conditions where bone marrow transplantation has shown remarkable success. High-dose chemotherapy followed by an allogeneic transplant can offer a chance of long-term remission for many patients.
Multiple myeloma, a cancer of the plasma cells in the bone marrow, has also benefited from bone marrow transplantation. Autologous transplants in multiple myeloma patients have shown promising results, often leading to a significant increase in life expectancy.
As research continues to advance, bone marrow transplantation is likely to play an even more significant role in cancer treatment. Scientists are exploring innovative techniques, such as haploidentical transplants.
ADDRESS: #13, East Spurtank Road, Chetpet, Chennai. +91 044 4600 8000, +91 99622 42000 www.vshospitals.com
WE PUSH THE LIMITS OF WHAT POSSIBLE FOR OUR PATIENTS